glp 1 agonist nash Upcoming GLP-1 RAs for NASH: A Comprehensive List Full article: GLP-1 receptor agonists

The 2026 Sports Medicine and JAAOS Global Research and Reviews papers (PMID 41966639, PMID 41490200) place multiple compounds including this one into the wider research context of unapproved compounds under active investigation, with attention to both the mechanism findings and the regulatory framing that researchers consulting these reviews should weigh equally

Indeed, Lall et al

This has implications for personalization of glucose control therapy

This autoimmune condition mainly affects the stomach

Finally, RNA sequencing results demonstrated that GSTM3 facilitates anti-tumorigenicity partly via the JAK-STAT signaling pathway in PC